Which test should be performed in a patient with sore throat and fever before prescribing antibiotics?

Rapid Antigen Detection Test (RADT) for Group A Streptococcus

You should perform a rapid antigen detection test (RADT) for Group A Streptococcus (GAS) before prescribing antibiotics to a patient with sore throat and fever, unless clear viral features are present (rhinorrhea, cough, oral ulcers, hoarseness). 1

Clinical Decision Algorithm

Step 1: Rule Out Viral Etiology

• Do NOT test if patient has obvious viral features: cough, rhinorrhea, hoarseness, or oral ulcers 1
• Do NOT test children under 3 years old (GAS pharyngitis uncommon in this age group and rheumatic fever risk is negligible) 1

Step 2: Apply Clinical Scoring (Optional but Recommended)

Use the Centor score (or modified Centor/FeverPAIN score) to stratify risk:

• 0-2 Centor criteria: No testing needed - very low probability of GAS 2
• 3-4 Centor criteria: Proceed with RADT - high probability warrants testing 2

The FeverPAIN score includes: Fever in past 24h, Purulence, Attends rapidly (within 3 days), Inflamed tonsils, No cough/coryza 3

Step 3: Perform RADT

• Swab the posterior pharyngeal wall and both tonsils for optimal accuracy 2
• Modern RADTs are highly specific (>95%), so positive results do not require culture confirmation 1

Step 4: Interpret Results

In Children and Adolescents:

• Positive RADT: Prescribe antibiotics - no backup culture needed 1
• Negative RADT: Perform backup throat culture (strong recommendation due to lower sensitivity and higher rheumatic fever risk) 1

In Adults:

• Positive RADT: Prescribe antibiotics 1
• Negative RADT: No backup culture needed in routine circumstances (GAS incidence and rheumatic fever risk are exceptionally low in adults) 1, 2

Why This Approach Matters for Patient Outcomes

Clinical features alone cannot reliably distinguish GAS from viral pharyngitis - this is the fundamental problem 1. Without testing, you face two poor outcomes:

1. Undertreating GAS: Misses the opportunity to reduce symptom duration and prevent suppurative complications
2. Overtreating viral pharyngitis: Exposes patients to unnecessary antibiotic side effects, drives antimicrobial resistance, and provides no benefit

Recent evidence demonstrates that RADT-guided antibiotic prescribing reduces antibiotic use by 38-41% without compromising patient health outcomes 4. Patients experience no difference in follow-up visits, days until pain resolution, or days of work/school missed 4.

Critical Nuances

The age-based difference in backup culture requirements reflects different risk-benefit calculations 1:

• Children have higher GAS prevalence (up to 47% in 6-10 year-olds) and face rheumatic fever risk 5
• Adults have lower GAS rates and negligible rheumatic fever risk, making false negatives less consequential

Clinical scores alone are insufficient. Even at the recommended FeverPAIN threshold (≥4), sensitivity is only 55% and specificity 77% 5. Using FeverPAIN alone would miss 44% of GAS-positive patients and result in unnecessary antibiotics for 23% of GAS-negative patients 5. This is why testing is essential - clinical judgment combined with RADT provides the optimal balance.

Common Pitfalls to Avoid

• Don't use empiric antibiotics based on clinical score alone in adults with high Centor scores (3-4) - this leads to 44% unnecessary antibiotic prescriptions 6
• Don't order throat cultures routinely - RADT is sufficient for initial testing 2
• Don't use biomarkers like CRP or procalcitonin for routine sore throat evaluation - they don't improve diagnostic accuracy for GAS 2
• Don't test asymptomatic household contacts - this leads to overtreatment of carriers 1

The evidence strongly supports RADT as the optimal first-line test, with age-appropriate backup strategies, to maximize appropriate antibiotic use while minimizing both undertreatment of bacterial infection and overtreatment of viral illness.